So you’re a big GoT fan, huh?
Do you think Jon Snow is the true heir to the Seven Kingdoms?
Come chat with us–Myriam, Ali, and Ellen–about all of the latest theories and shockers from this Sunday’s episode.
If you really want to talk shop though, and you’re interested in learning about how you can better measure binding affinity or characterize protein stability, we can do that too. Just let us know.
Myriam Badr, Ph.D.
Application Specialist
Ali Raja, Ph.D.
Sr. Application Specialist
Ellen Lee, Ph.D.
Application Specialist
Here’s a talk you won’t want to miss
Alexey Rak, Ph.D.
Head of Biostructure and Biophysics, Integrated Drug Discovery, Sanofi R&D, France
Integrating Novel Tools into Development Workflow of Biologics: NanoDSF and MST for Early Discovery and Developability Assessment
9:00 AM | THURSDAY, AUGUST 24
Modern drug discovery operations require characterization of biomolecular interactions to be both time- and cost-effective as well as to be highly precise and reproducible. Here we report applications of two novel predictive, precise, low protein consuming and high throughput methods: nano-Differential Scanning Fluorimetry (nanoDSF) and MicroScale Thermophoresis (MST) applied in our biologics discovery and characterization operations. Examples of the demonstrated effectiveness of the nanoDSF and MST will be discussed.
Looking to supe up your lab bench AND your research?
Stop by booth 509 to learn how to quickly and accurately characterize proteins with just a tiny amount of sample
Swiftly measure binding interactions and get accurate Kd results using very little sample with the Monolith system
Prometheus precisely characterizes thermal unfolding, chemical denaturation and aggregation in a single run with the most flexibility a system has to offer
